Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Clinical trial NCT06326736 · RECRUITING
Trial details
- NCT number
- NCT06326736
- Sponsor
- Jinling Hospital, China
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.